Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05918250
Title mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors ModernaTX, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
UAB Hospital Birmingham Alabama 35294 United States Details
University of Miami Health System Miami Florida 33136 United States Details
Washington University Medical Center Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
The Mount Sinai Hospital New York New York 10029 United States Details
Ohio State University Hospital Columbus Ohio 43210 United States Details
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
UW Medical Center Seattle Washington 98109 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Hôpital Maisonneuve-Rosemont Montréal Quebec H1T 2M4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field